Cocrystal Pharma
COCP • NASDAQ
Cocrystal Pharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sam Lee, with a market cap of $11.9M.
CEOSam Lee
Market Cap$11.9M
Biotechnology
Healthcare
Employees12.0
Websitecocrystalpharma.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Cocrystal Pharma
Date
Monday, March 30, 2026 (in 2 months)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.18
Earnings History
Past 12 earnings reports for Cocrystal Pharma
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q3 2025 | -$0.19Est: -$0.22 | +13.6% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.20Est: -$0.30 | +33.3% | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.23Est: -$0.50 | +54.0% | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.32Est: -$0.56 | +42.9% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.49Est: -$0.57 | +14.0% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.53Est: -$0.48 | -10.4% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.39Est: -$0.54 | +27.8% | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.44Est: -$0.60 | +26.7% | - | — | 10-K/A |
| Nov 13, 2023 | Q3 2023 | -$0.41Est: -$0.53 | +22.6% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.41Est: -$0.58 | +29.3% | -Est: $270.0K | -100.0% | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.64Est: -$0.59 | -8.5% | -Est: $170.0K | -100.0% | — |
| Mar 29, 2023 | Q4 2022 | -$0.54Est: -$0.73 | +26.0% | - | — | — |